Practices › Advanced Genetic Sequencing
Advanced Genetic Sequencing
Most Promising Segments “Advanced Genetic Sequencing”
-
Human Microbiome Market
The global human microbiome market, valued at US$623.3M in 2023, is forecasted to grow at a 31.5% CAGR, reaching US$814.6M by 2024 and US$4,206.0M by 2030.
-
Whole Exome Sequencing Market
This global whole exome sequencing market was valued at $326.6 million in 2013 and is expected to grow at a CAGR of 22.0% from 2013 to 2018, to reach $884.1 million by 2018. The market is dominat ...
-
Next-Generation Sequencing (NGS) Services Market
The global next-generation sequencing (NGS) services market is projected to reach USD 2,748.6 Million by 2022 from USD 1,059.2 Million in 2017; growing at a CAGR of 21.0%. As of 2016, the major N ...
-
Breast Cancer Liquid Biopsy Market
The global breast cancer liquid biopsy market is projected to grow at a CAGR of 23.1%. Factors such as increasing prevalence of breast cancer, increasing preference for noninvasive procedures, in ...
-
AI In Genomics Market
The global artificial intelligence in genomics market, valued at US$0.4B in 2022, is forecasted to grow at a 32.3% CAGR, reaching US$0.5B by 2023 and US$2.0B by 2028. The growth in this market is ...
-
AI in Precision Medicine Market
The global artificial intelligence in precision medicine market, valued at US$0.60B in 2023, is forecasted to grow at a 30.7% CAGR, reaching US$0.78B by 2024 and US$3.92B by 2030. Growth in preci ...
High Impact Segment
-
Cell Analysis Market
The global cell analysis market growth is primed to transition from $20.2 billion in 2023 to $33.9 billion by 2028, showcasing a strong CAGR of 10.9%. Increase in the preference for cell-bsaed as ...
-
Proteomics Market
The global proteomics market growth is primed to transition from USD 33.6 billion in 2024 to USD 60.5 billion by 2029, showcasing a strong CAGR of 12.4%. The major factors driving growth in the p ...
-
Genomics Market
The global genomics market, valued at US$42.4B in 2023, is forecasted to grow at a 9.4% CAGR, reaching US$42.6B by 2024 and US$66.8B by 2029. The main factors driving the expansion of this market ...
-
Cancer Biomarkers Market
The global cancer biomarkers market, valued at US$22.3B in 2023, is forecasted to grow at a 11.3% CAGR, reaching US$24.5B by 2024 and US$42.0B by 2029. The primary drivers of growth in this marke ...
-
Esoteric Testing Market
The global esoteric testing market, valued at US$29.9B in 2023, is forecasted to grow at a 8.5% CAGR, reaching US$32.2B by 2024 and US$48.3B by 2029. Growth in the market is primarily driven by t ...
-
Biomarker Technologies Market
The global biomarker technologies market is projected to grow at a CAGR of 9.7%. The key players in the biomarker technologies market are Thermo Fisher Scientific (US), Agilent Technologies (US), ...
Company
- THERMO FISHER SCIENTIFIC INC
- ILLUMINA INC
- QIAGEN NV
- AGILENT TECHNOLOGIES
- MERCK KGAA
- DANAHER CORPORATION
- EUROFINS
- BIO-RAD LABORATORIES INC
- PROMEGA CORPORATION
- ROCHE HOLDING AG
We can help find ?
Latent demand for you, for your prospective client, or your prospective partners
Our Team
-
Carl SchmidtStrategic Consultant Healthcare -
Shraddha ShrivastavaAssociate Manager Healthcare -
Vijendra AgarwalAssociate Manager Healthcare